Welcome to our dedicated page for TILRAY BRANDS news (Ticker: TLRY), a resource for investors and traders seeking the latest updates and insights on TILRAY BRANDS stock.
TIlray Brands, Inc. (TLRY) generates frequent news as a global lifestyle and consumer packaged goods company active across cannabis, beverage, wellness, and entertainment categories. Company updates often highlight developments in its cannabis brands, medical cannabis operations, beverage portfolio, and strategic corporate actions, giving investors and followers insight into how Tilray is executing its multi-category strategy.
News coverage commonly includes financial results and segment performance across cannabis, beverage, wellness, and distribution, as reflected in Tilray’s quarterly earnings releases. These updates may discuss trends in international medical cannabis revenue, Canadian adult-use cannabis sales, and distribution activity through Tilray Pharma. Corporate announcements, such as the implementation of a one-for-ten reverse stock split and related shareholder decisions, are also reported through press releases and SEC filings.
Tilray’s brand and product news provides detail on new launches and category expansion. Recent communications feature Dry January and holiday guides showcasing hemp-derived THC beverages, zero-proof spirits, non-alcoholic beers, and craft beers, as well as cannabis-infused beverages under brands like Mollo and XMG. Other releases focus on innovations in cannabis vapes and concentrates under brands such as Good Supply and Redecan, and curated cannabis gift guides that reflect consumer trends in Canada.
Regulatory and medical developments are another important theme. Tilray Medical has issued statements on U.S. federal cannabis rescheduling and the creation of Tilray Medical USA, outlining a framework for U.S. medical cannabis expansion based on experience in regulated international markets. For readers tracking TLRY, this news stream offers context on how the company responds to policy changes, evolves its brand portfolio, and communicates with shareholders. Bookmark this page to access an organized feed of Tilray’s earnings releases, product announcements, regulatory updates, and other material company news.
Tilray (Nasdaq: TLRY) announced a strategic German alliance effective April 1, 2026, joining Tilray Medical, CC Pharma, 14U Pharma and the "gesund leben" cooperation operated by Alliance Healthcare Deutschland.
The alliance leverages Alliance Healthcare's 27 logistics centers, daily supply to 10,000+ pharmacies, and the "gesund leben" network of ~3,600 member pharmacies to broaden pharmacy access, offer Rx, parallel-import discounts and Tilray's medical cannabis portfolio nationwide.
Tilray Brands (TLRY) brand Pub Beer launched Pub Light, an American-style light lager with 99 calories and 4% ABV. Brewed with 100% malt and no added sugar, corn, rice, or fillers, Pub Light is positioned as a clean, low-calorie option available now across the Pacific Northwest.
Packaging options include 16oz 6-packs and 12oz 18-packs, sold at select restaurants, bars, and retailers.
Tilray Brands (NASDAQ: TLRY) completed the acquisition of BrewDog Brewing Australia, including the Brisbane brewing facility and a portfolio of owned and franchised BrewDog bars across Australia on March 9, 2026. The deal positions Tilray to scale BrewDog in national retail and use Australia as a hub to expand its beverage portfolio across the Asia-Pacific region.
The purchase includes two owned Brisbane bars (DogTap Brisbane, BrewDog Fortitude Valley) and three franchised locations in Pentridge, South Eveleigh, and Perth.
Tilray Brands (Nasdaq: TLRY) completed acquisition of select BrewDog global assets for £33 million, including the global brand, UK brewing operations and 11 brewpubs. The acquired assets are expected to generate ~$200 million annual net revenue and $6–8 million adjusted EBITDA in fiscal 2027.
Tilray said the deal expands its global beverage platform to ~$500 million annual revenue and drives consolidated annualized revenue to ~$1.2 billion. U.S. and Australia assets remain subject to separate agreements expected to close in ~30 days.
Tilray Brands (NASDAQ: TLRY) expanded its Good Supply spring lineup across Canada on Feb 26, 2026, focusing on high‑potency vapes, flower, and expanded pre‑roll formats.
Key SKU highlights include two 1g 510 vape cartridges at 91–97% THC, new flower packs (28g, 7g) and limited drops with flower THC ranges of 24–32%. The collection is rolling out nationally in select formats and limited quantities; availability varies by province.
Tilray Brands (NASDAQ: TLRY) entered an exclusive multi-year U.S. licensing agreement with Carlsberg Group to produce, market, sell and distribute Carlsberg®, Carlsberg Elephant®, 1664®, and Kronenbourg 1664 Blanc® in the U.S., effective January 1, 2027.
The deal has an initial five-year term with an automatic five-year renewal tied to performance criteria; Tilray says the agreement will drive scale, revenue accretion at commencement, and better asset utilization across brewing, sourcing, packaging, and logistics.
Tilray (Nasdaq: TLRY) announced that CC Pharma has signed a strategic agreement with Smartway Pharmaceuticals to expand parallel import and specialist pharmaceutical supply across the United Kingdom, leveraging Smartway’s national distribution network and CC Pharma’s European procurement and GMP capacity.
The deal targets improved supply reliability for pharmacies and hospitals and supports Tilray’s broader European medical expansion and future access for its medicinal cannabis products.
Breckenridge Distillery (NASDAQ: TLRY) appointed Romano Beverage to manage statewide distribution in Illinois, covering its full spirits lineup including bourbon, whiskey, rum, vodka, gin, and the new Mountain Shot.
Romano will use its Elmhurst facility and local salesforce to provide logistics, retail activation, and on-premise support to expand Breckenridge's presence across Illinois.
Tilray (NASDAQ: TLRY) announced that CC Pharma, its European pharmaceutical distribution business, was named a TOP 100 Innovator in Germany on Feb 4, 2026. CC Pharma serves over 13,000 pharmacies nationwide and supports medical cannabis distribution using established infrastructure and regulatory expertise.
The award recognizes innovation management, forward-looking strategy, and sustainable competitiveness, and highlights CC Pharma’s regional footprint, digitalization efforts, and employer attractiveness within Germany’s healthcare supply chain.
Tilray Brands (NASDAQ: TLRY) is staging nationwide tap room promotions for Sunday, February 8, 2026, across its craft beer and distillery locations.
Participating brands include SweetWater, Montauk, Breckenridge, Blue Point, 10 Barrel, Hop Valley, Terrapin, and Atwater, offering game-day food, drink deals, extended hours, raffles, and to-go bundles with some preorder deadlines.